GC Therapeutics

Engimmune Therapeutics

This deep-tech company develops soluble T-cell receptor drugs for healthcare providers to treat patients with solid tumour cancers and immune-mediated diseases.

Axiom Therapeutics

This deep-tech company develops covalent medicines for pharmaceutical organisations using an artificial intelligence drug discovery platform.

GraphTX

The company develops a platform for precision drug discovery by mapping live patient immune cell behaviour to identify therapeutic targets for inflammatory diseases.

Tune Therapeutics

This deep-tech company develops epigenetic medicines that regulate gene activity to treat chronic and age-related diseases for the global healthcare market.

Granza Bio

This deep-tech company develops attack particle medicines to treat patients with cancer, autoimmune diseases and infections.

Arsenal Biosciences, Inc. (ArsenalBio)

This deep-tech company develops programmable T cell therapies for patients with solid tumours and autoimmune diseases.

Rewrite Therapeutics

This deep-tech company develops DNA writing and genome editing tools for biotechnology firms to treat genetic diseases.

Helix Nanotechnologies

This deep-tech company develops an mRNA platform to create vaccines and therapies for biotechnology organisations and patients with complex immune requirements.